China Universal Asset Management Company’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34.5K | Buy |
9,304
+17
| +0.2% | +$63 | ﹤0.01% | 439 |
|
|
2025
Q1 | $30K | Sell |
9,287
-515
| -5% | -$1.66K | ﹤0.01% | 446 |
|
|
2024
Q4 | $54.6K | Sell |
9,802
-193
| -2% | -$1.08K | 0.01% | 447 |
|
|
2024
Q3 | $108K | Buy |
9,995
+3,922
| +65% | +$42.4K | 0.01% | 352 |
|
|
2024
Q2 | $127K | Sell |
6,073
-3,506
| -37% | -$73.6K | 0.02% | 283 |
|
|
2024
Q1 | $305K | Buy |
9,579
+4,628
| +93% | +$147K | 0.04% | 242 |
|
|
2023
Q4 | $100K | Buy |
4,951
+3,873
| +359% | +$78.5K | 0.02% | 277 |
|
|
2023
Q3 | $13.7K | Buy |
1,078
+529
| +96% | +$6.73K | ﹤0.01% | 325 |
|
|
2023
Q2 | $9.92K | Buy |
549
+110
| +25% | +$1.99K | ﹤0.01% | 319 |
|
|
2023
Q1 | $7.55K | Buy |
439
+110
| +33% | +$1.89K | ﹤0.01% | 329 |
|
|
2022
Q4 | $7.31K | Buy |
329
+26
| +9% | +$577 | ﹤0.01% | 255 |
|
|
2022
Q3 | $2K | Buy |
+303
| New | +$2K | ﹤0.01% | 348 |
|